Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 33

1.

Reply by Authors.

Claros OR, Tourinho-Barbosa RR, Fregeville A, Gallardo AC, Muttin F, Carneiro A, Stabile A, Moschini M, Macek P, Cathala N, Mombet A, Sanchez-Salas R, Cathelineau X.

J Urol. 2020 Feb 20:101097JU000000000000069203. doi: 10.1097/JU.0000000000000692.03. [Epub ahead of print] No abstract available.

PMID:
32077801
2.

Comparison of Initial Experience with Transrectal Magnetic Resonance Imaging Cognitive Guided Micro-Ultrasound Biopsies versus Established Transperineal Robotic Ultrasound Magnetic Resonance Imaging Fusion Biopsies for Prostate Cancer.

Claros OR, Tourinho-Barbosa RR, Fregeville A, Gallardo AC, Muttin F, Carneiro A, Stabile A, Moschini M, Macek P, Cathala N, Mombet A, Sanchez-Salas R, Cathelineau X.

J Urol. 2019 Dec 10:101097JU0000000000000692. doi: 10.1097/JU.0000000000000692. [Epub ahead of print]

PMID:
31821099
3.

Reply by Authors.

Tourinho-Barbosa RR, Sanchez-Salas R, Claros OR, Collura-Merlier S, Bakavicius A, Carneiro A, Stabile A, Moschini M, Cathala N, Tobias-Machado M, Cathelineau X.

J Urol. 2020 Feb;203(2):329-330. doi: 10.1097/01.JU.0000614908.52884.48. Epub 2019 Nov 13. No abstract available.

PMID:
31721682
4.

HIFU focal therapy for prostate cancer using intraoperatory contrast enhanced ultrasound.

Claros OR, Tourinho-Barbosa RR, Carneiro A, Collura-Merlier S, Macek P, Lanz C, Cathala N, Prapotnich D, Mombet A, Sanchez-Salas R, Cathelineau X.

Arch Esp Urol. 2019 Oct;72(8):825-830.

PMID:
31579041
5.

Focal Therapy for Localized Prostate Cancer with Either High Intensity Focused Ultrasound or Cryoablation: A Single Institution Experience.

Tourinho-Barbosa RR, Sanchez-Salas R, Claros OR, Collura-Merlier S, Bakavicius A, Carneiro A, Stabile A, Moschini M, Cathala N, Tobias-Machado M, Cathelineau X.

J Urol. 2020 Feb;203(2):320-330. doi: 10.1097/JU.0000000000000506. Epub 2019 Aug 22.

PMID:
31437121
6.

Long-term functional and oncological outcomes of nerve-sparing and prostate capsule-sparing cystectomy: a single-centre experience.

Saad M, Moschini M, Stabile A, Macek P, Lanz C, Prapotnich D, Rozet F, Cathala N, Mombet A, Sanchez-Salas R, Cathelineau X.

BJU Int. 2020 Feb;125(2):253-259. doi: 10.1111/bju.14850. Epub 2019 Jul 12.

PMID:
31220396
7.

Comprehensive Evaluation of Focal Therapy Complications in Prostate Cancer: A Standardized Methodology.

Bakavicius A, Sanchez-Salas R, Muttin F, Sivaraman A, Dell'Oglio P, Barret E, Rozet F, Mombet A, Prapotnich D, Cathala N, Cathelineau X.

J Endourol. 2019 Jul;33(7):509-515. doi: 10.1089/end.2018.0809. Epub 2019 May 31.

PMID:
31017001
8.

Immediate versus delayed prostatectomy and the fate of patients who progress to a higher risk disease on active surveillance.

Mallya A, Senguttuvan-Karthikeyan V, Sivaraman A, Barret E, Galiano M, Cathala N, Mombet A, Prapotnich D, Sanchez-Salas R, Cathelineau X.

Actas Urol Esp. 2019 Jul - Aug;43(6):324-330. doi: 10.1016/j.acuro.2018.04.005. Epub 2019 Mar 28. English, Spanish.

PMID:
30928176
9.

Oncological outcomes and pathological characteristics of cT1 upstaging to pT3a renal cell carcinoma compared with de novo pT3a tumors.

Senguttuvan Karthikeyan V, Mallya A, Sivaraman A, Galiano M, Rozet F, Cathala N, Barret E, Mombet A, Prapotnich D, Sanchez-Salas R, Cathelineau X.

Actas Urol Esp. 2019 Jun;43(5):234-240. doi: 10.1016/j.acuro.2018.03.008. Epub 2019 Mar 8. English, Spanish.

PMID:
30857765
10.

Switch from abiraterone plus prednisone to abiraterone plus dexamethasone at asymptomatic PSA progression in patients with metastatic castration-resistant prostate cancer.

Fenioux C, Louvet C, Charton E, Rozet F, Ropert S, Prapotnich D, Barret E, Sanchez-Salas R, Mombet A, Cathala N, Joulia ML, Molitor JL, Henriques J, Bonnetain F, Cathelineau X, Bennamoun M.

BJU Int. 2019 Feb;123(2):300-306. doi: 10.1111/bju.14511. Epub 2018 Sep 4.

11.

[Management of ablative therapies in prostate cancer].

Barret E, Sanchez-Salas R, Galiano M, Cathala N, Mombet A, Prapotnich D, Rozet F, Gangi A, Lang H, Cathelineau X.

Prog Urol. 2017 Nov;27(15):909-925. doi: 10.1016/j.purol.2017.07.243. Epub 2017 Sep 15. Review. French.

PMID:
28918872
12.

Systematic review of perioperative outcomes and complications after open, laparoscopic and robot-assisted radical cystectomy.

Palazzetti A, Sanchez-Salas R, Capogrosso P, Barret E, Cathala N, Mombet A, Prapotnich D, Galiano M, Rozet F, Cathelineau X.

Actas Urol Esp. 2017 Sep;41(7):416-425. doi: 10.1016/j.acuro.2016.05.009. Epub 2016 Nov 28. Review. English, Spanish.

PMID:
27908634
13.

Recovery of urinary continence after radical prostatectomy.

Capogrosso P, Sanchez-Salas R, Salonia A, Cathala N, Mombet A, Sivaraman A, Barret E, Montorsi F, Cathelineau X.

Expert Rev Anticancer Ther. 2016 Oct;16(10):1039-52. doi: 10.1080/14737140.2016.1233818. Epub 2016 Sep 21. Review.

PMID:
27636115
14.

High intensity focused ultrasound with Focal-One® device: Prostate-specific antigen impact and morbidity evaluation during the initial experience.

Perez-Reggeti JI, Sanchez-Salas R, Sivaraman A, Linares Espinos E, de Gracia-Nieto AE, Barret E, Galiano M, Rozet F, Fregeville A, Renard-Penna R, Cathala N, Mombet A, Prapotnich D, Cathelineau X.

Actas Urol Esp. 2016 Dec;40(10):608-614. doi: 10.1016/j.acuro.2016.04.016. Epub 2016 Aug 16. English, Spanish.

PMID:
27543259
15.

Focal High-intensity Focused Ultrasound Targeted Hemiablation for Unilateral Prostate Cancer: A Prospective Evaluation of Oncologic and Functional Outcomes.

Feijoo ER, Sivaraman A, Barret E, Sanchez-Salas R, Galiano M, Rozet F, Prapotnich D, Cathala N, Mombet A, Cathelineau X.

Eur Urol. 2016 Feb;69(2):214-20. doi: 10.1016/j.eururo.2015.06.018. Epub 2015 Jul 9.

PMID:
26164416
16.

Clinical utility of transperineal template-guided mapping biopsy of the prostate after negative magnetic resonance imaging-guided transrectal biopsy.

Sivaraman A, Sanchez-Salas R, Ahmed HU, Barret E, Cathala N, Mombet A, Uriburu Pizarro F, Carneiro A, Doizi S, Galiano M, Rozet F, Prapotnich D, Cathelineau X.

Urol Oncol. 2015 Jul;33(7):329.e7-11. doi: 10.1016/j.urolonc.2015.04.005. Epub 2015 May 6.

PMID:
25957713
17.

Evolution from laparoscopic to robotic nephron sparing surgery: a high-volume laparoscopic center experience on achieving 'trifecta' outcomes.

Carneiro A, Sivaraman A, Sanchez-Salas R, Di Trapani E, Barret E, Rozet F, Galiano M, Pizzaro FU, Doizi S, Cathala N, Mombet A, Prapotnich D, Cathelineau X.

World J Urol. 2015 Dec;33(12):2039-44. doi: 10.1007/s00345-015-1552-1. Epub 2015 Apr 14.

PMID:
25869814
18.

Robotics in urological surgery: evolution, current status and future perspectives.

Sivaraman A, Sanchez-Salas R, Prapotnich D, Barret E, Mombet A, Cathala N, Rozet F, Galiano M, Cathelineau X.

Actas Urol Esp. 2015 Sep;39(7):435-41. doi: 10.1016/j.acuro.2014.10.009. Epub 2015 Mar 21. Review. English, Spanish.

PMID:
25801676
19.

Evaluation of erectile function after laparoscopic radical prostatectomy in a single center.

Cathala N, Mombet A, Sanchez-Salas R, Rozet F, Barret E, Giuliano F, Galiano M, Prapotnich D, Kazzazi A, Djavan B, Jaffe J, Cathelineau X, Vallancien G.

Can J Urol. 2012 Aug;19(4):6328-35.

PMID:
22892254
20.

[Effect of wound infiltration of ropivacaine in postoperative pain after extraperitoneal laparoscopic radical prostatectomy].

Berthon N, Plainard X, Cathelineau X, Rozet F, Cathala N, Mombet A, Galiano M, Prapotnich D, Barret E, Vallancien G.

Prog Urol. 2010 Jun;20(6):435-9. doi: 10.1016/j.purol.2009.12.003. French.

PMID:
20538208
21.

Laparoscopic radical prostatectomy is feasible and effective in 'fit' senior men with localized prostate cancer.

Sanchez-Salas R, Prapotnich D, Rozet F, Mombet A, Cathala N, Barret E, Galiano M, Cathelineau X, Vallancien G.

BJU Int. 2010 Nov;106(10):1530-6. doi: 10.1111/j.1464-410X.2010.09295.x.

22.

A 16-year clinical experience with intermittent androgen deprivation for prostate cancer: oncological results.

Prapotnich D, Cathelineau X, Rozet F, Barret E, Mombet A, Cathala N, Sanchez-Salas RE, Vallancien G.

World J Urol. 2009 Oct;27(5):627-35. doi: 10.1007/s00345-009-0393-1. Epub 2009 Feb 27.

PMID:
19247669
23.

Characterization of a selenate-resistant Arabidopsis mutant. Root growth as a potential target for selenate toxicity.

El Kassis E, Cathala N, Rouached H, Fourcroy P, Berthomieu P, Terry N, Davidian JC.

Plant Physiol. 2007 Mar;143(3):1231-41. Epub 2007 Jan 5.

24.

Extraperitoneal laparoscopic radical prostatectomy: a prospective evaluation of 600 cases.

Rozet F, Galiano M, Cathelineau X, Barret E, Cathala N, Vallancien G.

J Urol. 2005 Sep;174(3):908-11.

PMID:
16093985
25.

Structural and functional analysis of the C-terminal STAS (sulfate transporter and anti-sigma antagonist) domain of the Arabidopsis thaliana sulfate transporter SULTR1.2.

Rouached H, Berthomieu P, El Kassis E, Cathala N, Catherinot V, Labesse G, Davidian JC, Fourcroy P.

J Biol Chem. 2005 Apr 22;280(16):15976-83. Epub 2005 Feb 16.

26.

Laparoscopic sacral colpopexy approach for genito-urinary prolapse: experience with 363 cases.

Rozet F, Mandron E, Arroyo C, Andrews H, Cathelineau X, Mombet A, Cathala N, Vallancien G.

Eur Urol. 2005 Feb;47(2):230-6.

PMID:
15661419
27.

[Laparoscopic surgery for renal cancers].

Vallancien G, Cathala N, Cathelineau X, Rozet F.

Bull Acad Natl Med. 2004;188(1):39-45; discussion 45. French.

PMID:
15368924
28.

Patient followup after radical prostatectomy by Internet medical file.

Cathala N, Brillat F, Mombet A, Lobel E, Prapotnich D, Alexandre L, Vallancien G.

J Urol. 2003 Dec;170(6 Pt 1):2284-7.

PMID:
14634397
29.

[Follow-up, with Internet medical file, of patients who have undergone radical prostatectomy].

Vallancien G, Cathala N, Brillat F, Mombet A, Lobel E, Prapotnich D, Alexandre L.

Bull Acad Natl Med. 2002;186(7):1289-97; discussion 1297-9. French.

PMID:
12669667
30.

A 10-year clinical experience with intermittent hormonal therapy for prostate cancer.

Prapotnich D, Fizazi K, Escudier B, Mombet A, Cathala N, Vallancien G.

Eur Urol. 2003 Mar;43(3):233-39; discussion 239-40.

PMID:
12600425
31.

Cloning and characterization of a root specific high-affinity sulfate transporter from Arabidopsis thaliana.

Vidmar JJ, Tagmount A, Cathala N, Touraine B, Davidian JE.

FEBS Lett. 2000 Jun 9;475(1):65-9.

32.

Supplemental Content

Loading ...
Support Center